Acrivon Therapeutics, Inc. Common Stock (ACRV) — Financial Flexibility Index
Acrivon Therapeutics, Inc. Common Stock (ACRV) has a Financial Flexibility Index of -0.68x as of September 2025. Free cash flow of $-11.38 Million (operating CF $-12.28 Million minus capex $899.00K) represents -1% of total liabilities ($16.70 Million). Check ACRV strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Acrivon Therapeutics, Inc. Common Stock Financial Flexibility Index (2020–2024)
Historical Financial Flexibility Index trend for Acrivon Therapeutics, Inc. Common Stock across 5 annual periods. See Acrivon Therapeutics, Inc. Common Stock short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Acrivon Therapeutics, Inc. Common Stock (2020–2024)
Year-by-year free cash flow to debt coverage for Acrivon Therapeutics, Inc. Common Stock. For the full company profile including market capitalisation, see ACRV market cap overview.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -3.18x | $-62.90 Million | $-65.67 Million | $19.80 Million | ▼ -31.1% |
| 2023 | -2.42x | $-41.35 Million | $-42.64 Million | $17.07 Million | ▲ +6.8% |
| 2022 | -2.60x | $-27.95 Million | $-30.12 Million | $10.75 Million | ▼ -2366.6% |
| 2021 | -0.11x | $-13.74 Million | $-13.98 Million | $130.40 Million | ▲ +59.9% |
| 2020 | -0.26x | $-2.79 Million | $-2.80 Million | $10.60 Million | — |